Literature DB >> 23871168

History of trauma and the association with baseline symptoms in an Ultra-High Risk for psychosis cohort.

Eva Velthorst1, Barnaby Nelson, Karen O'Connor, Nilufar Mossaheb, Lieuwe de Haan, Annie Bruxner, Magenta B Simmons, Alison R Yung, Andrew Thompson.   

Abstract

Few studies have addressed the correlates of trauma in young people at Ultra-High Risk (UHR) of developing a psychotic disorder. We aimed to examine baseline differences in intensity, form and content of attenuated positive psychotic symptoms, other clinical symptomatology and comorbidity between UHR patients with and without a history of trauma. In a sample of 127 UHR individuals (53 male, 74 female; mean age 18.2 years, range 14-26) we assessed trauma history and baseline symptomatology using an audit tool developed to retrieve data from patient medical records. 56% of the subjects had experienced at least one type of trauma. The intensity of perceptual abnormalities was significantly higher in the group with a history of physical abuse and 'other trauma' compared to those without a trauma history. Physical abuse was related to higher levels of visual disturbances, suspiciousness, grandiose beliefs and low mood compared to those without a history of physical abuse. Sexual trauma was related to perceptual disturbances with abusive content and PTSD symptoms. The prevalence of previous trauma in people at UHR of developing psychosis is high. Our findings tentatively suggest that different types of trauma may impact differently on initial presentation to UHR services.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Attenuated positive symptoms; Clinical symptomatology; Psychosis; Trauma; Ultra High Risk

Mesh:

Year:  2013        PMID: 23871168     DOI: 10.1016/j.psychres.2013.06.007

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

1.  Changes in symptom content from a clinical high-risk state to conversion to psychosis.

Authors:  Catherine Marshall; Yun Lu; Kristina Lyngberg; Stephanie Deighton; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel Mathalon; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2017-08-03       Impact factor: 2.732

Review 2.  Trauma and the psychosis spectrum: A review of symptom specificity and explanatory mechanisms.

Authors:  Lauren E Gibson; Lauren B Alloy; Lauren M Ellman
Journal:  Clin Psychol Rev       Date:  2016-08-31

3.  The content of attenuated psychotic symptoms in those at clinical high risk for psychosis.

Authors:  Catherine Marshall; Erin Denny; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Scott W Woods; Elaine Walker; Jean Addington
Journal:  Psychiatry Res       Date:  2014-06-21       Impact factor: 3.222

4.  Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis.

Authors:  Jacqueline Stowkowy; Lu Liu; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Jean Addington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-02-06       Impact factor: 4.328

5.  Childhood trauma and clinical high risk for psychosis.

Authors:  Rachel L Loewy; Sarah Corey; Felix Amirfathi; Sawsan Dabit; Daniel Fulford; Rahel Pearson; Jessica P Y Hua; Danielle Schlosser; Barbara K Stuart; Daniel H Mathalon; Sophia Vinogradov
Journal:  Schizophr Res       Date:  2018-05-18       Impact factor: 4.939

6.  Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety.

Authors:  Yun Lu; Catherine Marshall; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel Mathalon; Jean Addington
Journal:  Psychiatry Res       Date:  2017-08-31       Impact factor: 3.222

7.  The Violent Content in Attenuated Psychotic Symptoms.

Authors:  Catherine Marshall; Stephanie Deighton; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel Mathalon; Jean Addington
Journal:  Psychiatry Res       Date:  2016-05-07       Impact factor: 3.222

8.  The 4th Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: a summary of topics and trends.

Authors:  Olukayode Abayomi; Davide Amato; Candace Bailey; Byron Bitanihirwe; Lynneice Bowen; Shimon Burshtein; Alexis Cullen; Montserrat Fusté; Ana P Herrmann; Babak Khodaie; Sanja Kilian; Qortni A Lang; Elizabeth E Manning; Raffael Massuda; Milawaty Nurjono; Sarosh Sadiq; Teresa Sanchez-Gutierrez; Tamara Sheinbaum; Venkataram Shivakumar; Nicholas Simon; Anneliese Spiteri-Staines; Suttajit Sirijit; Nanna Gilliam Toftdahl; Sunali Wadehra; Yi Wang; Rebekah Wigton; Susan Wright; Sergey Yagoda; Yuliya Zaytseva; Anne O'Shea; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2014-10-11       Impact factor: 4.939

9.  Life Event Stress and Reduced Cortical Thickness in Youth at Clinical High Risk for Psychosis and Healthy Control Subjects.

Authors:  Katrina Aberizk; Meghan A Collins; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Scott W Woods; Tyrone D Cannon; Elaine F Walker
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2021-04-28

10.  Social and spatial heterogeneity in psychosis proneness in a multilevel case-prodrome-control study.

Authors:  J B Kirkbride; J Stochl; J Zimbrón; C M Crane; A Metastasio; E Aguilar; R Webster; S Theegala; N Kabacs; P B Jones; J Perez
Journal:  Acta Psychiatr Scand       Date:  2014-12-31       Impact factor: 6.392

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.